|
| Press Releases |
|
 |
|
| Wednesday, July 16, 2025 |
|
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today |
| more info >> |
|
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today |
| On the morning of 15 July 2025, China Medical System Holdings Limited ("CMS" or the "Group") rang the ceremonial bell to mark its official listing on the Singapore Exchange Main Board (Stock Abbreviation: CMS, Stock Code: 8A8). more info >> |
|
| Wednesday, June 25, 2025 |
|
|
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange |
| more info >> |
|
|
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange |
| more info >> |
|
| Friday, March 21, 2025 |
|
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum |
| On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of RMB7,469 million, representing a year-on-year decrease of 6.8%; in the case that all medicines were directly sold by the Company, the turnover would be RMB8,622 million, representing a year-on-year decrease of 9.0%. more info >> |
|
| Friday, February 14, 2025 |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| more info >> |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited ("CMS" or the "Group") has been included in the S&P Global Sustainability Yearbook 2025 (the "Yearbook 2025"). more info >> |
|
| Friday, January 24, 2025 |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| more info >> |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 more info >> |
|
| Thursday, January 9, 2025 |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
WPS AI 3.0 Launches to Strengthen Office Software Business
Aug 20, 2025 23:29: JST
|
|
|
Rust Mobile首次封閉測試定於11月開啟
Aug 20, 2025 23:00 HKT/SGT
|
|
|
Rust Mobile首次封闭测试定于11月开启
Aug 20, 2025 23:00 HKT/SGT
|
|
|
Rust Mobile's 1st Closed Beta Set for November
Aug 20, 2025 23:00 HKT/SGT
|
|
|
WPS AI 3.0 Launches to Strengthen Office Software Business
Aug 20, 2025 22:29 HKT/SGT
|
|
|
HKTDC Chairman promotes Hong Kong's business advantages in Thailand
Aug 20, 2025 22:10 HKT/SGT
|
|
|
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
Aug 20, 2025 21:30: JST
|
|
|
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
Aug 20, 2025 20:30 HKT/SGT
|
|
|
創新疫苗引擎持續驅動 康希諾開啟新增長週期
Aug 20, 2025 20:22 HKT/SGT
|
|
|
创新疫苗引擎持续驱动 康希诺开启新增长周期
Aug 20, 2025 20:02 HKT/SGT
|
|
|
Graphene Manufacturing Group Ltd. Announces Bought Public Offering of Units for Gross Proceeds of C$5 Million
Aug 20, 2025 19:59 HKT/SGT
|
|
|
Hengdeli Announces 2025 Interim Results
Aug 20, 2025 19:52 HKT/SGT
|
|
|
亨得利2025年中期業績發佈 堅持行穩致遠 保生存謀發展
Aug 20, 2025 19:52 HKT/SGT
|
|
|
Emperor W&J Announces 2025 Interim Results, Revenues from Hong Kong and Mainland China Increase by 9% Respectively
Aug 20, 2025 19:00 HKT/SGT
|
|
|
英皇鐘錶珠寶公佈2025年中期業績 來自香港及中國內地之收入分別上升9%
Aug 20, 2025 18:34 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
